Perkinelmer and M.d. Anderson Cancer Centre Collaborate

PerkinElmer is undertaking to train students in Molecular Genetic Technology (MGT) at The University of Texas M.D. Anderson Cancer
Centre in the use of the company`s Array Comparative Genomic Hybridization (aCGH) technology. aCGH is analogous to traditional
karyotyping but is said to offer greater throughput, resolution and ease of use. The company is also to support two student research projects for presentation at genomics and cytogenetics conferences to increase the medical community`s understanding of the utility of Array CGH.

“We were thrilled to forge a relationship with M. D. Anderson to support their cancer research and train their technologists in this powerful technique,” said Ann-Christine Sundell, President, Genetic Screening, PerkinElmer. “The MGT students at M. D. Anderson will benefit
from this learning experience via a hands-on perspective," says Peter Hu, Ph.D. Director for the MGT programme.

“We felt this venture was such a win-win situation for everyone involved,” says Alan Lennon, Ph.D. Education Coordinator for the MGT programme. The technique will allow scientists to learn more cytogenetically about samples in less time, enabling researchers to
advance the pace of their cancer research.